Infrequent zoledronate dosing may reduce the risk for fracture over 10 years in postmenopausal women, while preserving bone mineral density.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback